About: Etidronic acid     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/drugbank/Drug, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
http://linked.open...gbank/description
  • A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover. [PubChem] (en)
http://linked.open...y/drugbank/dosage
http://linked.open...gy/drugbank/group
  • approved (en)
http://linked.open...drugbank/halfLife
  • In normal subjects, plasma half-life of etidronic acid, based on non-compartmental pharmacokinetics is 1 to 6 hours. (en)
http://linked.open...ugbank/indication
  • For the treatment of symptomatic Paget's disease of bone and in the prevention and treatment of heterotopic ossification following total hip replacement or due to spinal cord injury. (en)
sameAs
Title
  • Etidronic acid (en)
adms:identifier
http://linked.open...mechanismOfAction
  • Bisphosphonates, when attached to bone tissue, are absorbed by osteoclasts, the bone cells that breaks down bone tissue. Although the mechanism of action of non-nitrogenous bisphosphonates has not been fully elucidated, available data suggest that they bind strongly to hydroxyapatite crystals in the bone matrix, preferentially at the sites of increased bone turnover and inhibit the formation and dissolution of the crystals. Other actions may include direct inhibition of mature osteoclast function, promotion of osteoclast apoptosis, and interference with osteoblast-mediated osteoclast activation. Etidronic acid does not interfere with bone mineralization. In malignancy-related hypercalcemia, etidronic acid decreases serum calcium by inhibiting tumour-induced bone resorption and reducing calcium flow from the resorbing bone into the blood. Etidronic acid also reduces morbidity of osteolytic bone metastases by inhibiting tumour-induced bone resorption. Etidronic acid may promote osteoclast apoptosis by competing with adenosine triphosphate (ATP) in the cellular energy metabolism. The osteoclast initiates apoptosis and dies, leading to an overall decrease in the breakdown of bone. (en)
http://linked.open...drugbank/packager
http://linked.open...outeOfElimination
  • Etidronate disodium is not metabolized. Within 24 hours, approximately half the absorbed dose is excreted in urine; the remainder is distributed to bone compartments from which it is slowly eliminated. Unabsorbed drug is excreted intact in the feces. (en)
http://linked.open.../drugbank/synonym
  • Acetodiphosphonic acid (en)
  • EHDP (en)
  • Etidronate (en)
  • Etidronsaeure (en)
  • HEDP (en)
  • Hydroxyethanediphosphonic acid (en)
  • Oxyethylidenediphosphonic acid (en)
  • (1-Hydroxyethylene)diphosphonic acid (en)
  • (1-Hydroxyethylidene)bis(phosphonic acid) (en)
  • (1-Hydroxyethylidene)bisphosphonic acid (en)
  • (1-Hydroxyethylidene)diphosphonic acid (en)
  • (Hydroxyethylidene)diphosphonic acid (en)
  • 1,1,1-Ethanetriol diphosphonate (en)
  • 1-Hydroxy-1,1-diphosphonoethane (en)
  • 1-Hydroxyethane-1,1-bisphosphonic acid (en)
  • 1-Hydroxyethane-1,1-diphosphonate (en)
  • 1-Hydroxyethane-1,1-diphosphonic acid (en)
  • 1-Hydroxyethanediphosphonic acid (en)
  • 1-Hydroxyethylidene-1,1-bisphosphonate (en)
  • 1-Hydroxyethylidene-1,1-diphosphonic acid (en)
  • 1-hydroxyethane 1,1-diphosphonic acid (en)
  • Acide etidronique (en)
  • Acido etidronico (en)
  • Acidum etidronicum (en)
  • Ethane-1-hydroxy-1,1-bisphosphonic acid (en)
  • Ethane-1-hydroxy-1,1-diphosphonate (en)
  • Ethane-1-hydroxy-1,1-diphosphonic acid (en)
  • Etidronsäure (en)
http://linked.open...drugbank/toxicity
  • Clinical experience with acute etidronic acid overdosage is extremely limited. Decreases in serum calcium following substantial overdosage may be expected in some patients. Signs and symptoms of hypocalcemia also may occur in some of these patients. Some patients may develop vomiting. In one event, an 18-year-old female who ingested an estimated single dose of 4800 to 6000 mg (67 to 100 mg/kg) of etidronate was reported to be mildly hypocalcemic (7 .5 2 mg/ dl) and experienced paresthesia of the fingers. (en)
http://linked.open.../drug/hasAHFSCode
http://linked.open...k/foodInteraction
  • Avoid aluminium, calcium, iron and magnesium within 2 hours of taking medication. (en)
  • Take on an empty stomach with a full glass of water. (en)
http://linked.open.../drugbank/mixture
http://linked.open...ogy/drugbank/salt
  • (en)
http://linked.open...ynthesisReference
  • Rogovin, L.,Brawn, D.P. and Kalberg, AN.; US. Patent 3,400,147; September 3,1968; assigned to The Procter & Gamble Co. (en)
foaf:page
http://linked.open...ugbank/IUPAC-Name
http://linked.open...gy/drugbank/InChI
http://linked.open...Molecular-Formula
http://linked.open.../Molecular-Weight
http://linked.open...noisotopic-Weight
http://linked.open...y/drugbank/SMILES
http://linked.open.../Water-Solubility
http://linked.open...ogy/drugbank/logP
http://linked.open...ogy/drugbank/logS
http://linked.open...l/drug/hasATCCode
http://linked.open...nd-Acceptor-Count
http://linked.open...-Bond-Donor-Count
http://linked.open...drugbank/InChIKey
http://linked.open...urface-Area--PSA-
http://linked.open...nk/Polarizability
http://linked.open...bank/Refractivity
http://linked.open...atable-Bond-Count
http://linked.open...ugbank/absorption
  • The amount of drug absorbed after an oral dose is approximately 3%. (en)
http://linked.open.../affectedOrganism
  • Humans and other mammals (en)
http://linked.open...casRegistryNumber
  • 7414-83-7 (en)
http://linked.open...drugbank/category
  • (en)
http://linked.open...gbank/containedIn
http://linked.open...k/Bioavailability
http://linked.open...bank/Ghose-Filter
http://linked.open...nk/MDDR-Like-Rule
http://linked.open...k/Number-of-Rings
http://linked.open...siological-Charge
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software